SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Drugs
Drugs
Page 27 of 28
Features
FDA approves the first biosimilar for the U.S. market
By
Laura Lorenzetti
March 6, 2015
Finance
AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal
By
Reuters
March 5, 2015
Retail
Rite Aid takes aim at CVS with a $2 billion purchase
By
Laura Lorenzetti
February 11, 2015
Features
Biosimilars may one day save your life. But what are they?
By
Laura Lorenzetti
February 6, 2015
Finance
After Allergan loss, is Valeant dumpster diving?
By
Jen Wieczner
January 31, 2015
How to stop generic drug shortages: end hospital group purchasing kickbacks
By
Phillip L. Zweig
and
Robert A. Campbell
January 30, 2015
Report predicts 18 states will legalize pot by 2020
By
TIME
January 26, 2015
Features
Regeneron vaults ahead of Amgen in race to market cholesterol drug
By
Reuters
January 26, 2015
Retail
High stakes: How this marijuana company gained buzz in a budding market
By
Entrepreneur
and
Ben Geier
December 26, 2014
Leadership
The war on drugs comes to Corporate America
By
Chris Matthews
December 2, 2014
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By
Laura Lorenzetti
December 2, 2014
International
Merck buys the rights to an experimental Ebola vaccine
By
Reuters
November 24, 2014
Features
5 things that will kill you before Ebola does
By
Verne Kopytoff
October 30, 2014
International
Hands off our hookers’ and dope dealers’ money, U.K. tells E.U.
By
Geoffrey Smith
October 24, 2014
International
Spain gets a questionable GDP boost, thanks to drugs and prostitution
By
Ian Mount
October 8, 2014
Most Popular
Commentary
My wife sold her engagement ring to pay our tax bill. It led to my PhD and my career tackling the student-debt crisis
By
Brian Walsh
Success
AI expert says it’s ‘not a question’ that AI will take over all jobs—but people will have 80 hours a week of free time
By
Emma Burleigh
Economy
Congressional Budget Office says Trump's immigration crackdown will shrink U.S. population faster than expected, a...
By
Sasha Rogelberg